Tekla Life Sciences Investors

NYSE:HQL

Asset Management

Financial Services
$19.27 +0.62%

+$0.11 today

Market cap
$585.96M
Beta
0.73
P/E (TTM)
2.8
EPS (TTM)
$6.52
Dividend yield
11.35%
52W Low $12.34High $18.46

Volume 0.12M

Average 0.11M

HQL Interest Income

Income earned on cash, deposits, and investments held by the company.

Tekla Life Sciences InvestorsNYSE: HQL

Interest Income · Q2 FY2026 · quarter ended Mar 2026

Interest income remains negative

Q2 FY2026 interest income was $533.2K, compared with $0 a year earlier. Over 3 fiscal years it compounded at +91.1% a year.

Context

  • Interest income amounted to 0.4% of revenue in FY2025, down 0.8 pp from a year earlier.
  • Interest income increased in 2 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$533.2K— QoQ
Last fiscal yearSep 2025
$349.84K-66.5% YoY
Interest Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year-66.5%——
3-year CAGR+91.1%——
5-year CAGR——
10-year CAGR——

Interest Income history

USD · from the income statement

Latest · FY2025
349.84K USD
Year-over-year change
-66.5%

Interest Income vs competitors

How HQL compares with its peers on the latest reported figures

  • HQL's FY2025 interest income of $349.84K is the 9th highest of the 10 companies compared; the peer median is $94.76M.
  • Its year-over-year change of -66.5% is the 8th highest of 9, against a peer median of -2.7%.
  • Interest income amounts to 0.4% of revenue for HQL, versus a peer median of 115.2%.
HQL Competitors Peer median
Interest Income for HQL and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CIONCION Investment CorporationLTM Mar 2026$207.71M +5.3%+6.3%140.6%
TCPCBlackRock TCP Capital Corp.LTM Mar 2026$185.48M -27.1%+7.0%758.6%
CCAPCrescent Capital BDC, Inc.LTM Mar 2026$157.58M -10.8%+996.2%126.3%
ECCEagle Point Credit Company Inc.LTM Dec 2025$142.34M —+22.5%84.9%
PNNTPennantPark Investment CorporationLTM Mar 2026$94.76M -14.7%+3.9%115.2%
GLADGladstone Capital CorporationLTM Mar 2026$94.51M +5.9%+17.4%134.0%
GAINGladstone Investment CorporationLTM Mar 2026$91.09M +8.9%+16.7%81.1%
SORSource Capital, Inc.FY2025$20.73M +39.0%+29.6%43.9%
HQLTekla Life Sciences InvestorsFY2025$349.84K -66.5%+91.1%0.4%
MCIBarings Corporate InvestorsLTM Jun 2025$0 -100.0%+8.3%0.0%
Peer median (excluding HQL) $94.76M-2.7%+16.7%115.2%

Competitors are the stored peer set for HQL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Sep 2021
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Revenue45.02M31.86M39.39M86.69M86.39M
Cost of Revenue6.08M5.55M5.24M5.36M4.97M
Gross Profit38.95M26.31M18.28M86.69M86.39M
Gross Margin86.5%82.6%46.4%100.0%100.0%
Research & Development0(3)000
Selling, General & Admin844.02K1.08M903.14K1.33M743.17K
Operating Expenses1.16M1.35M1.17M1.39M791.57K
Depreciation & Amortization4.14M2.99M27.6M1.92M0
EBITDA68.68M(101.62M)49.95M87.22M85.59M
EBITDA Margin152.5%-318.9%126.8%100.6%99.1%
Operating Income64.53M(104.6M)(5.24M)85.3M85.59M
Operating Margin143.3%-328.3%-13.3%98.4%99.1%
Interest Income050.09K204.45K1.04M349.84K
Interest Expense00000
Other Income / Expenses(7.83K)2.42K27.6M87.22M0
Income Before Tax64.53M(104.6M)22.35M85.3M85.59M
Pre-Tax Margin143.3%-328.3%56.8%98.4%99.1%
Income Tax Expense00000
Net Income64.53M(104.6M)22.35M85.3M85.59M
Net Margin143.3%-328.3%56.8%98.4%99.1%
EPS (Basic)2.66(4.07)0.793.042.96
EPS (Diluted)2.66(4.07)0.793.042.96
Weighted Avg Shares24.26M25.68M28.29M28.06M28.87M
Weighted Avg Shares (Diluted)24.26M25.68M28.29M28.06M28.87M

Tekla Life Sciences Investors

NYSE:HQL

Intrinsic Alpha fair value

Locked

Current Price

$19.27

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.